Ardent Health, Inc. (ARDT) Earnings Call Transcripts
Ardent Health, Inc.'s Latest Earnings Call - June 10, 2026
In the second quarter of fiscal year 2026, Ardent Health, Inc. reported a revenue of $1.2 billion, which was in line with expectations, while reaffirming its guidance for the year despite observed volume softness across its portfolio. The company is focusing on operational improvements and margin expansion, with management highlighting an increase in their impact program savings target from $45 million to $55 million. The transition to a new CEO is seen as a proactive move to enhance operational execution amid industry challenges, signaling a strategic shift towards outpatient care and disciplined M&A activity.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $1.2B (inline) |
| Impact Program Savings Target | $55M (positive) |
| CapEx as % of Revenue | over 3% (positive) |
| M&A Capacity | $1B (neutral) |
| Denial Activity | stabilized (positive) |
| Urgent Care Locations | 46 (positive) |
Guidance from management
Management reaffirmed their guidance for fiscal year 2026, indicating confidence in achieving their targets despite current volume softness.
What management said
Well, I think it's -- yes, no, good question, and I think it's -- I'll say at a personal level, the easiest answer, and that is, Dave has proven himself inside of the organization over the past 15 months and executed at a level that has accelerated and enhanced our operational position. And in terms of really demonstrating that this was a proactive move and not a reactive move. I think that's probably no further evid...
Sure. Absolutely. Yes, I have really had the pleasure working with Dave for 15 months. I tell people who I met and ask about Dave, he is an extraordinary leader from the standpoint of creating. He is 1 of the most authentic, consistent and accountable driven leaders that I've worked with in my career. And I think, yes, if I were to highlight 3 strengths, it would be just those things. And I think those are the dime...
What analysts pressed on
Analysts expressed concerns regarding the volume softness impacting revenue growth and the potential challenges posed by increased denial rates. There was also inquiry into how the new CEO would navigate these industry headwinds.
Main topics on the call
- CEO Transition — Management emphasized that the CEO transition was a 'proactive move' to enhance operational execution. New CEO Dave Styblo is expected to bring a higher level of operational rigor, which is crucial given the anticipated ...
- Impact Program Savings — The target for the impact program savings has been raised from '$45 million' to '$55 million' for fiscal year 2026, showcasing management's commitment to operational efficiency and margin improvement.
- Volume Softness — Management acknowledged 'volume softness' across the portfolio, particularly in surgical procedures, attributing this trend to a shift towards outpatient settings. This is a concern as it may impact revenue growth moving...
- Outpatient Strategy — Ardent is focusing on expanding its outpatient footprint, having increased urgent care locations to 46. The company plans to build more ambulatory surgical centers (ASCs) to meet consumer demand for lower-cost care optio...
Read the full Ardent Health, Inc. transcript (June 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Ardent Health, Inc.
Ardent Health, Inc. (ARDT) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 15 calls on record spanning August 15, 2024 to August 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 15 Ardent Health, Inc. earnings call transcripts on record, spanning August 15, 2024 to August 5, 2026. Based on this history, Ardent Health, Inc. reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ARDT
- Exchange
- NYSE
- Country
- US
- Sector
- Health Care
- Calls on record
- 15
- First call
- August 15, 2024
- Most recent
- August 5, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 5, 2026 | Read transcript → |
| Company Conference Presentations | Jun 10, 2026 | Read transcript → |
| Company Conference Presentations | May 13, 2026 | Read transcript → |
| Q1 FY2026 | May 6, 2026 | Read transcript → |
| Q4 FY2025 | Mar 5, 2026 | Read transcript → |
| Q3 FY2025 | Nov 13, 2025 | Read transcript → |
| Company Conference Presentations | Sep 8, 2025 | Read transcript → |
| Q2 FY2025 | Aug 6, 2025 | Read transcript → |
| Company Conference Presentations | May 14, 2025 | Read transcript → |
| Q1 FY2025 | May 7, 2025 | Read transcript → |
| Q4 FY2024 | Feb 27, 2025 | Read transcript → |
| Company Conference Presentations | Jan 14, 2025 | Read transcript → |
| Q3 FY2024 | Nov 7, 2024 | Read transcript → |
| Company Conference Presentations | Sep 5, 2024 | Read transcript → |
| Q2 FY2024 | Aug 15, 2024 | Read transcript → |